RYTM R&D Expenses

Rhythm Pharmaceuticals Inc · R&D Expenses

RYTM logo

RYTM R&D Expenses

Latest reported$173.21M
RYTM TTM R&D Expenses ($5.40M → $173.21M)
High-resolution chart · PNG

RYTM r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rhythm Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
173,212,000
172,092,000
167,340,000
166,475,000
158,380,000
146,089,000
237,590,000
226,314,000
221,953,000
225,479,000
134,950,000
128,606,000
116,152,000
114,065,000
108,630,000
116,656,000
123,079,000
116,727,000
104,128,000
94,508,000
89,964,000
87,857,000
90,450,000
93,306,000
96,883,000
109,194,000
109,451,000
103,404,000
87,537,000
60,813,000
50,338,000
38,228,000
33,494,000
30,307,000
22,894,000
21,872,000
21,320,000
20,457,000
19,594,000
17,581,000
14,360,000
10,492,000
7,148,000
4,149,000
2,012,000
3,707,000
5,402,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.